…the Vienna Biocenter is a hot spot for the life sciences?

…currently, around 1.400 scientists and more than 1.000 students from over 40 nations are working and studying at the VBC?

…16 biotech companies, four basic research institutes, one university of applied science, one science communication association, one business incubator and one public relations agency are located on the Vienna Biocenter?

…IMBA and the association Open Science run the Vienna Open Lab to make the life sciences accessible to the interested public?

…up to 90.000 m² of office and lab space are already in use at the VBC?

…the VBC has it's own Science Support Facilities (VBCF), providing top scientific infrastructure and a child care center?

…scientists at the VBC have received 40 ERC Grants since 2007, raising up to 70 million EUR?

…11 Wittgenstein Awards were received by researchers at the VBC?

Research Excellence at Vienna Biocenter: 40 ERC grants

The European Research Council (ERC) was founded by the EU in 2007 to fund outstanding science. 10 years later, ERC grants stand out as the most prestigious award for high quality research in Europe.

The sole selection criterion for an ERC grant is scientific excellence. The process is so competitive that only 11% of applications are funded. However, the talented scientists at the VBC dramatically outperform the average, with an impressive funding rate of almost 60%.

In total, the institutes at the Vienna Biocenter have hosted an impressive 40 ERC grants over the last 10 years: 22 Starting Grants, 5 Consolidator Grants, 12 Advanced Grants and 1 Proof of Concept. These grants have brought 70 million EUR of funding.

Vienna Biocenter is the No. 1 life-science location in Austria in terms of ERC grants, and a main player for life-sciences research in Europe!

The Vienna Biocenter at a glance

Thermo Fisher Scientific acquires Affymetrix eBioscience

Founding of the Vienna Doctoral School “Molecules of Life” at MFPL

5 years anniversary VBCF

15 years anniversary GMI

Completion of new IMP building


Groundbreaking for new IMP building

US-based Horizon Discovery acquires Haplogen Genomics

Relocation of INITS Business Incubator to VBC

Apeiron Biologicals enters cooperation with Evotec and Sanofi to develop cancer immunotherapies

MFPL Symposium
on the occasion of the 100th birthday of Nobel Laureate Max F. Perutz


Intercell and Vivalis fuse to form Valneva

Jan-Michael Peters becomes director of IMP

10 years anniversary of AFFiRiS, FH Campus Wien, IMBA and MFPL

Completion of the Marx Box

US-based Affymetrix acquires eBioscience

Successful participation of the VBC in the nation-wide “Long Night of Research”

VBCF - Child Care service expands to include the Media Quartier

Relocation of the University of Applied Sciences (FH Campus Wien) to the Marx Box

10 years anniversary of GMI

Founding of the Vienna Biocenter Core Facilities (VBCF - formerly Campus Support Facilities) with public funding by federal government and city of Vienna of up to 52 Mio € by 2020

Vienna Biocenter Summer School for talented undergraduates established

Apeiron Biologics concluded deal with GlaxoSmithKline Biologicals

Establishment of the day care center for campus children

Magnus Nordborg joins GMI as scientific director

Organisation of the EU-project “European Researchers Night” in the Marx Halle (formerly Rinderhalle)

US-based eBioscience establishes its center of excellence for immunoassays by acquisition of Bender Med Systems

Completion of the Solaris building (lab and office area of 9,000 sqm) and start of construction work of the Marx Box

20 years anniversary of IMP celebrated with scientific conference at Hofburg Conference Center

AFFiRiS concluded business-deal with GlaxoSmithKline Biologicals

Start of construction work for laboratory building CVBC 3

Graham Warren joins MFPL as director

Barry Dickson becomes director of IMP

Austrian Academy of Sciences opens the Life Sciences Centre Vienna hosting IMBA and GMI

Opening of the Vienna Open Lab at IMBA as a joint initiative of Open Science and IMBA

Founding of the Max F. Perutz Laboratories (MFPL) as joint venture of Medical University of Vienna and University of Vienna

IPO of Intercell at the Viennese stock exchange

Diagnostics company Bender MedSystems opened an office in the US

Completion of laboratory building CVBC 2

Establishment of two institutes of the Austrian Academy of Sciences on the Campus (IMBA with founding director Josef Penninger and GMI with founding director Dieter Schweizer)

Founding of AFFiRiS

Founding of University of Applied Sciences (FH Campus Wien) in Biotechnology at the Campus


Relocation of six biotech companies to the Campus (e.g. Genosense, VBC Genomics)

Founding of the Campus Vienna Biocenter Association

Relocation of Bender MedSystems to the Campus

Founding of Intercell as a spin-off of the University of Vienna and IMP

Kim Nasmyth becomes director of IMP

Founding of the initiative „Gentechnik & Wir“ (now Open Science)

Founding of VBC PhD Programme

Relocation of five university departments to the Campus (now MFPL)

Opening of IMP with founding director Max Birnstiel


Since 1988, the Vienna Biocenter (VBC) has developed into one of the most outstanding and prominent life sciences hubs not only in Austria but also in the Central European Region.